Design and synthesis of orally active inhibitors of TNF synthesis as anti-rheumatoid arthritis drugs.
A novel series of TNF inhibitors was identified based on the screening of existing MMP inhibitor libraries. Further SAR optimization led to the discovery of a novel lead compound. Its synthesis, efficacy in experimental animal models, and pharmacokinetic data are discussed.